HCM
PFE icon

Horan Capital Management’s Pfizer PFE Stock Holding History

Horan Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-265,219
Closed -$8.93M – 68
2018
Q1 		$8.93M Sell
265,219
-11,842
-4% -$407K 1.94% 20
2017
Q4 		$9.52M Sell
277,061
-13,741
-5% -$469K 1.89% 22
2017
Q3 		$9.85M Sell
290,802
-3,803
-1% -$122K 2.05% 20
2017
Q2 		$9.39M Sell
294,605
-2,899
-1% -$91.4K 2.05% 21
2017
Q1 		$9.66M Sell
297,504
-1,873
-0.6% -$59.1K 2.2% 18
2016
Q4 		$9.22M Buy
299,377
+5,389
+2% +$165K 2.39% 18
2016
Q3 		$9.45M Sell
293,988
-4,837
-2% -$162K 2.51% 18
2016
Q2 		$9.98M Sell
298,825
-4,511
-1% -$144K 2.76% 15
2016
Q1 		$8.53M Buy
303,336
+23,652
+8% +$676K 2.37% 18
2015
Q4 		$8.56M Sell
279,684
-8,336
-3% -$262K 2.38% 16
2015
Q3 		$8.58M Sell
288,020
-2,585
-0.9% -$82.9K 2.52% 17
2015
Q2 		$9.24M Sell
290,605
-7,757
-3% -$253K 2.6% 19
2015
Q1 		$9.85M Sell
298,362
-7,551
-2% -$240K 2.78% 19
2014
Q4 		$9.04M Sell
305,913
-8,765
-3% -$251K 3.12% 18
2014
Q3 		$8.83M Sell
314,678
-10,104
-3% -$284K 2.98% 20
2014
Q2 		$9.14M Sell
324,782
-8,679
-3% -$247K 3.1% 18
2014
Q1 		$10.2M Sell
333,461
-20,176
-6% -$602K 3.51% 15
2013
Q4 		$10.3M Sell
353,637
-15,174
-4% -$442K 3.52% 14
2013
Q3 		$10.1M Sell
368,811
-7,761
-2% -$211K 3.82% 12
2013
Q2 		$10M Buy
+376,572
New +$10.4M 3.94% 12

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horan Capital Management's PFE Position: Q2 2018 in Review

Horan Capital Management sold out of Pfizer (PFE) in Q2 2018, closing a stake of 265,219 shares — an estimated $8.93M sold.

Horan Capital Management first reported a position in PFE in Q2 2013 and held it in 20 quarters. The position peaked at $10.3M in Q4 2013. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Horan Capital Management reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Horan Capital Management sold 265,219 Pfizer shares in Q2 2018, an estimated $8.93M.
  • Horan Capital Management first reported a position in Pfizer in Q2 2013 and held it in 20 quarters.
  • Horan Capital Management's Pfizer position peaked at $10.3M in Q4 2013.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Horan Capital Management's 13F filing for Q2 2018, filed 27 Jul 2018.